ABOUT THE PROJECT
NEOLIVER is a Horizon Europe research and innovation project developing world’s first autologous bioprinted liver which will be validated in large animal models. Our ultimate goal is to produce dense, vascularized bioprinted liver constructs suitable for clinical use as an Advance Therapy Medicinal Product (ATMP).
NEOLIVER will tackle key technological challenges and barriers in whole organ engineering by merging two bioprinting technologies and exploring five innovation routes:
1
Scaling up spheroid production and automation.
2
Laser-induced-forward-transfer (LIFT)-enabled dual-material bioprinting and synthetic hydrogels.
3
Vascularization of large tissue constructs
4
Anastomosis of a bioprinted construct.
5
Good Manufacturing Practice and acceptance.
THE TEAM
